Literature DB >> 11590034

Insulin therapies - past, present and future.

O Pillai1, R Panchagnula.   

Abstract

The discovery of insulin is one of the greatest milestones in medical history. This discovery revolutionized the use of peptides and proteins as therapeutic agents. For more than six decades, insulin from different animal sources was used, until the breakthrough in biotechnology made it possible to produce human insulin in sufficient amounts. The evolution of the biotechnological era gave rise to modified insulins to solve some of the bottlenecks in insulin therapy. Efforts are currently focused towards developing non-invasive insulin delivery systems, and there are several competing technologies in different stages of development. The next few years will see several novel approaches to mimic the endogenous release and kinetics of insulin, and also many improved analogues designed to achieve better control and effective treatment of diabetes.

Entities:  

Year:  2001        PMID: 11590034     DOI: 10.1016/s1359-6446(01)01962-6

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

1.  Formulating insulin for oral administration: preparation of hyaluronan-insulin complex.

Authors:  Gustaf Jederstrom; Arne Andersson; Johan Gråsjö; Ingvar Sjöholm
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

2.  Application of SIMSTEX to oligomerization of insulin analogs and mutants.

Authors:  Raghu K Chitta; Don L Rempel; Michael A Grayson; Edward E Remsen; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2006-09-06       Impact factor: 3.109

3.  Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies.

Authors:  Reshma D'Souza; Srinivas Mutalik; Madhavacharya Venkatesh; Sudha Vidyasagar; Nayanabhirama Udupa
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

4.  Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.

Authors:  Maryam Mansourpour; Reza Mahjub; Mohsen Amini; Seyed Naser Ostad; Elnaz Sadat Shamsa; Morteza Rafiee-Tehrani; Farid Abedin Dorkoosh
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

5.  Tyrosine autofluorescence as a measure of bovine insulin fibrillation.

Authors:  Innocent B Bekard; Dave E Dunstan
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

6.  Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected].

Authors:  N Tennagels; S Welte; M Hofmann; P Brenk; R Schmidt; U Werner
Journal:  Diabetologia       Date:  2013-05-08       Impact factor: 10.122

7.  Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin.

Authors:  Shaoping Sun; Na Liang; Yoshiaki Kawashima; Dengning Xia; Fude Cui
Journal:  Int J Nanomedicine       Date:  2011-11-28

8.  Multifunctional Composite Microcapsules for Oral Delivery of Insulin.

Authors:  Shaoping Sun; Na Liang; Xianfeng Gong; Weiwei An; Yoshiaki Kawashima; Fude Cui; Pengfei Yan
Journal:  Int J Mol Sci       Date:  2016-12-28       Impact factor: 5.923

9.  Nanoparticles Prepared From N,N-Dimethyl-N-Octyl Chitosan as the Novel Approach for Oral Delivery of Insulin: Preparation, Statistical Optimization and In-vitro Characterization.

Authors:  Elnaz Sadat Shamsa; Reza Mahjub; Maryam Mansoorpour; Morteza Rafiee-Tehrani; Farid Abedin Dorkoosh
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 10.  Plant Platforms for Efficient Heterologous Protein Production.

Authors:  Siddhesh B Ghag; Vinayak S Adki; Thumballi R Ganapathi; Vishwas A Bapat
Journal:  Biotechnol Bioprocess Eng       Date:  2021-08-07       Impact factor: 2.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.